Frélii, Inc. Stock

FRLI

US3570511010

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 15:22:04 2026-07-13 EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-

20-12-16	Frélii, Inc. cancelled the acquisition of 25% shares of Genecor AI Inc. from Helix Investment Partners LLC.	CI
20-01-08	Frélii, Inc. announced that it has received $0.203 million in funding	CI

Frelii, Inc. provides Web-based nutrition and fitness programs based on usersâ€™ genetic data. The Company provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies usersâ€™ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Companyâ€™s site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The Company provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. It provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume

Delayed Quote OTC Markets

More quotes

Stock Market
Stocks
FRLI Stock

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	11.76M 10.33M 9.61M 8.82M 16.57M 1.13B 16.82M 114M 44.57M 557M 44.16M 43.21M 1.93B	P/E 2017	21.4x	P/E 2018	-12.5x
Enterprise Value	11.7M 10.28M 9.56M 8.77M 16.48M 1.13B 16.74M 114M 44.35M 554M 43.94M 42.99M 1.92B	EV / Sales 2017	-	EV / Sales 2018	2,167,635,443x
Free-Float	100%	Yield 2017 *	-	Yield 2018	-

20-12-16	Frélii, Inc. cancelled the acquisition of 25% shares of Genecor AI Inc. from Helix Investment Partners LLC.	CI
20-01-08	Frélii, Inc. announced that it has received $0.203 million in funding	CI
19-12-22	Frélii, Inc. entered into share purchase agreement to acquire 25% shares of Genecor AI Inc. for $0.94 million from Helix Investment Partners LLC.	CI
19-11-14	Frélii, Inc. announced that it has received $0.154 million in funding	CI
19-11-14	Frélii, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	CI
19-08-14	Frélii, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	CI
19-07-16	Frelii, Inc. Announces Resignation of Leslie Norris as Chief Operating Officer; Opens Its First Wholly Owned Subsidiary, Frelii Canada Inc. in Mississauga, Ontario, Canada	CI
19-06-10	Frélii, Inc. Inks Agreement with Orn Health Inc. to Support Healthcare Franchisee Partners Incorporating Pharmacogentics Into Patient Treatment	CI
19-05-22	Frelii Inc. Announces Executive Changes	CI
19-05-20	Frélii, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	CI
19-05-01	Frélii, Inc. Signs Contract and Licensing Agreement with Optivida Health	CI
19-04-16	Frélii, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	CI
19-04-12	Frélii, Inc. Announces Address Change	CI

Current year	0		0
1 year	0		0
3 years	0		0.04
5 years	0		0.04
10 years	0		10

Manager	Title	Age	Since
Ian Jenkins CEO	Chief Executive Officer	42	2017-04-04
Jayson Uffens CTO	Chief Tech/Sci/R&D Officer	51	2018-05-14
Hans Jenkins CTO	Chief Tech/Sci/R&D Officer	49	2018-03-26

Director	Title	Age	Since
Ian Jenkins BRD	Director/Board Member	42	2017-04-04
Tarek Mango BRD	Director/Board Member	55	2017-12-31
Hans Jenkins BRD	Director/Board Member	49	2018-03-26

Frélii, Inc. Stock

Stocks

FRLI

US3570511010

Advanced Medical Equipment & Technology

Valuation: Frélii, Inc.

Chart: Frélii, Inc.

Latest news : Frélii, Inc.

Course Extremes

Managers and Directors: Frélii, Inc.

Medical Software & Technology Services

Financials

Company Profile

Quotes

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
FRÉLII, INC.	0.00%	0.00%	-	-	58
VEEVA SYSTEMS INC.	+3.71%	-4.68%	-36.05%	-5.45%	30.25B
PRO MEDICUS LIMITED	-1.42%	-14.59%	-50.04%	+138.50%	11.68B
SECTRA AB	+1.76%	-3.42%	-27.38%	+57.74%	5.28B
HEARTFLOW, INC.	-1.99%	-3.05%	-	-	2.08B
OMNICELL, INC.	+2.86%	-10.62%	+45.75%	-34.09%	1.86B
GENERATE BIOMEDICINES, INC.	-3.11%	-1.18%	-	-	1.72B
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	-3.12%	-3.55%	-39.08%	-	1.03B
ARBUTUS BIOPHARMA CORPORATION	-2.01%	-3.95%	+35.19%	+102.78%	865M
B-SOFT CO.,LTD.	-4.53%	-4.82%	-44.46%	-57.70%	723M
Average	-0.79%	-5.04%	-16.58%	+33.63%	5.55B
Weighted average by Cap.	+1.67%	-6.65%	-34.36%	+34.36%

	2017	2018
Net sales	-	0.04 0.03 0.03 0.03 0.05 3.46 0.05 0.35 0.14 1.7 0.13 0.13 5.88
Net income	595K 523K 486K 446K 839K 57.35M 852K 5.78M 2.26M 28.19M 2.24M 2.19M 97.48M	-5.55M -4.87M -4.53M -4.16M -7.82M -534M -7.94M -53.83M -21.03M -263M -20.83M -20.38M -908M
Net Debt	37.06K 32.55K 30.27K 27.78K 52.2K 3.57M 53K 359K 140K 1.75M 139K 136K 6.07M	-58.56K -51.43K -47.83K -43.89K -82.47K -5.64M -83.74K -568K -222K -2.77M -220K -215K -9.59M